LifeStance Health Group, Inc. (NASDAQ:LFST – Get Free Report) Director Darren Black sold 5,899,661 shares of the firm’s stock in a transaction that occurred on Tuesday, May 12th. The shares were sold at an average price of $8.02, for a total transaction of $47,315,281.22. Following the completion of the transaction, the director owned 23,310,115 shares of the company’s stock, valued at approximately $186,947,122.30. This trade represents a 20.20% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
LifeStance Health Group Stock Down 3.0%
Shares of NASDAQ LFST opened at $7.65 on Friday. The company has a 50 day simple moving average of $6.88 and a 200 day simple moving average of $6.79. The firm has a market cap of $2.97 billion, a PE ratio of 127.50 and a beta of 1.20. LifeStance Health Group, Inc. has a 1 year low of $3.74 and a 1 year high of $8.89. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.48 and a quick ratio of 1.65.
LifeStance Health Group (NASDAQ:LFST – Get Free Report) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.04 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.03. The business had revenue of $403.48 million during the quarter, compared to analyst estimates of $387.46 million. LifeStance Health Group had a net margin of 1.55% and a return on equity of 1.56%. The company’s revenue for the quarter was up 21.2% on a year-over-year basis. On average, research analysts forecast that LifeStance Health Group, Inc. will post 0.12 EPS for the current year.
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the stock. Larson Financial Group LLC lifted its position in shares of LifeStance Health Group by 19,952.6% during the 4th quarter. Larson Financial Group LLC now owns 3,810 shares of the company’s stock valued at $27,000 after acquiring an additional 3,791 shares during the period. KBC Group NV acquired a new position in shares of LifeStance Health Group during the 1st quarter valued at $29,000. PNC Financial Services Group Inc. lifted its position in shares of LifeStance Health Group by 615.3% during the 1st quarter. PNC Financial Services Group Inc. now owns 9,285 shares of the company’s stock valued at $59,000 after acquiring an additional 7,987 shares during the period. Assetmark Inc. lifted its position in shares of LifeStance Health Group by 17.0% during the 1st quarter. Assetmark Inc. now owns 9,419 shares of the company’s stock valued at $60,000 after acquiring an additional 1,367 shares during the period. Finally, Bayesian Capital Management LP acquired a new position in shares of LifeStance Health Group during the 2nd quarter valued at $52,000. Institutional investors and hedge funds own 85.50% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of research analysts recently issued reports on the stock. Canaccord Genuity Group raised their price objective on shares of LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a report on Thursday, February 26th. Weiss Ratings upgraded shares of LifeStance Health Group from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday, February 27th. Barclays raised their price target on shares of LifeStance Health Group from $8.00 to $9.00 and gave the stock an “overweight” rating in a report on Friday, March 6th. Jefferies Financial Group upgraded shares of LifeStance Health Group to a “strong-buy” rating in a report on Thursday, March 12th. Finally, Wall Street Zen upgraded shares of LifeStance Health Group from a “hold” rating to a “buy” rating in a report on Sunday, February 8th. Two equities research analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat.com, LifeStance Health Group currently has an average rating of “Buy” and a consensus target price of $9.86.
Get Our Latest Stock Report on LFST
LifeStance Health Group Company Profile
LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.
The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.
Featured Stories
- Five stocks we like better than LifeStance Health Group
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for LifeStance Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeStance Health Group and related companies with MarketBeat.com's FREE daily email newsletter.
